ClinicalTrialsFinder

Acute Lymphoblastic Leukemia, Adult Clinical Trials in Heidelberg

1 recruitingHeidelberg, Germany

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR

Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+3 more
University Hospital Heidelberg68 enrolled2 locationsNCT03676504